-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Assumes Sana Biotechnology at Overweight, Announces Price Target of $12

Benzinga·07/03/2025 17:21:29
Listen to the news
Morgan Stanley analyst Maxwell Skor assumes Sana Biotechnology (NASDAQ:SANA) with a Overweight rating and announces Price Target of $12.